Open access · CC-BY
via OpenAlex
MULTIOMIC SYSTEMS ANALYSIS OF LIFESPAN-EXTENDING INTERVENTIONS IN MOUSE TISSUES
Kengo Watanabe, Tomasz Maciej Wilmanski, Priyanka Baloni, Max Robinson, Oliver Fiehn, Robert L. Moritz, Richard A. Miller, Noa Rappaport
Innovation in Aging · 2023
Abstract
Abstract Aging is associated with dysregulation of molecular, cellular, and physiological processes. Nutritional and pharmacological interventions with different postulated modes of action have been shown to extend lifespan and delay aging-related diseases in model organisms, suggesting the existence of core cellular processes that mediate the effect on lifespan and healthspan(definition). However, these underlying molecular processes remain largely uncharacterized. In this study, we analyzed multiomic tissue-derived data of lifespan-extending interventions in mice including metabolomics and proteomics from the NIA Longevity Consortium and previously reported transcriptomics. We applied three systems techniques, differential rank conservation (DIRAC) analysis, weighted gene co-expression network analysis (WGCNA), and mouse genome-scale metabolic model (GEM) reconstruction, to the mouse liver proteomic and transcriptomic datasets of lifespan-extending interventions (e.g., acarbose, 17α-estradiol, and mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition)). We found that these interventions generally strengthen the rank conservation of biological processes and shift metabolic fluxes, with fatty acid metabolism emerging as a common process affected by multiple interventions. We then applied these approaches to an expanded experimental data with additional interventions (e.g., canagliflozin) and tissues (e.g., kidney, muscle, and plasma), confirming our results and further observing varied inter-omic and inter-tissue patterns exerted by lifespan-extending interventions. Our findings highlight the potential of integrative systems analysis to elucidate common and unique cellular and physiological changes relating to aging and lifespan-extending interventions, which have translational potential as preventive and prognostic measures to improve human health.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/geroni/igad104.3000
- Canonical
- link ↗
- Fetched
- 2026-10-12 MST
Cite this
APA
Watanabe, K., Wilmanski, T.M., Baloni, P., Robinson, M., Fiehn, O., Moritz, R.L., Miller, R.A., & Rappaport, N. (2023). MULTIOMIC SYSTEMS ANALYSIS OF LIFESPAN-EXTENDING INTERVENTIONS IN MOUSE TISSUES. <em>Innovation in Aging</em>. https://doi.org/10.1093/geroni/igad104.3000
Vancouver
Watanabe K, Wilmanski TM, Baloni P, Robinson M, Fiehn O, Moritz RL, et al. MULTIOMIC SYSTEMS ANALYSIS OF LIFESPAN-EXTENDING INTERVENTIONS IN MOUSE TISSUES. Innovation in Aging. 2023. doi:10.1093/geroni/igad104.3000.
BibTeX
@article{kengo2023MULTIO,
title = {MULTIOMIC SYSTEMS ANALYSIS OF LIFESPAN-EXTENDING INTERVENTIONS IN MOUSE TISSUES},
author = {Kengo Watanabe and Tomasz Maciej Wilmanski and Priyanka Baloni and Max Robinson and Oliver Fiehn and Robert L. Moritz and Richard A. Miller and Noa Rappaport},
journal = {Innovation in Aging},
year = {2023},
doi = {10.1093/geroni/igad104.3000},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Communications Biology 2023
Open access · CC-BY
Lifespan-extending interventions induce consistent patterns of fatty acid oxidation in mouse livers
Nature Communications 2023
Open access · CC-BY
Sis2 regulates yeast replicative lifespan in a dose-dependent manner
bioRxiv (Cold Spring Harbor Laboratory) 2025
Preprint · CC-BY
Exposing the core genetic drivers of chronological aging in yeast cells
2025
Preprint
Exposing the core genetic drivers of chronological aging in yeast cells
Aging 2026
Citation only
mTOR signaling in aging: from causality to geroprotective interventions and hallmark-level outcomes
Aging 2026
Citation only